Ayr Wellness Gelecekteki Büyüme
Future kriter kontrolleri 1/6
Ayr Wellness is forecast to grow earnings and revenue by 32.1% and 7.6% per annum respectively while EPS is expected to grow by 42% per annum.
Anahtar bilgiler
32.1%
Kazanç büyüme oranı
42.0%
EPS büyüme oranı
Pharmaceuticals kazanç büyümesi | 54.4% |
Gelir büyüme oranı | 7.6% |
Gelecekteki özkaynak getirisi | n/a |
Analist kapsamı | Good |
Son güncelleme | 29 Oct 2024 |
Gelecekteki son büyüme güncellemeleri
Recent updates
Ayr Wellness Inc.'s (CSE:AYR.A) 29% Share Price Surge Not Quite Adding Up
Nov 03Ayr Wellness (CSE:AYR.A) Has Debt But No Earnings; Should You Worry?
Oct 23Ayr Wellness Inc. (CSE:AYR.A) Not Doing Enough For Some Investors As Its Shares Slump 28%
Aug 28Does Ayr Wellness (CSE:AYR.A) Have A Healthy Balance Sheet?
Jul 17Ayr Wellness Inc.'s (CSE:AYR.A) Shares Not Telling The Full Story
May 24Is Ayr Wellness Inc. (CSE:AYR.A) Worth CA$2.1 Based On Its Intrinsic Value?
Dec 22Is Ayr Wellness (CSE:AYR.A) Using Debt Sensibly?
Oct 06Ayr Wellness Inc.'s (CSE:AYR.A) Share Price Boosted 33% But Its Business Prospects Need A Lift Too
Sep 01Ayr Wellness Inc. (CSE:AYR.A) Stock Catapults 33% Though Its Price And Business Still Lag The Industry
Sep 01Is There An Opportunity With Ayr Wellness Inc.'s (CSE:AYR.A) 33% Undervaluation?
Jul 11What You Need To Know About The Ayr Wellness Inc. (CSE:AYR.A) Analyst Downgrade Today
Aug 19Does Ayr Wellness (CSE:AYR.A) Have A Healthy Balance Sheet?
Jul 23Kazanç ve Gelir Büyüme Tahminleri
Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
---|---|---|---|---|---|
12/31/2026 | 573 | N/A | N/A | N/A | 1 |
12/31/2025 | 542 | -117 | -1 | 38 | 5 |
12/31/2024 | 483 | -213 | -6 | 26 | 6 |
6/30/2024 | 465 | -191 | -7 | 25 | N/A |
3/31/2024 | 464 | -183 | -12 | 26 | N/A |
12/31/2023 | 464 | -86 | -12 | 27 | N/A |
9/30/2023 | 463 | -190 | -12 | 26 | N/A |
6/30/2023 | 457 | -206 | -36 | 6 | N/A |
3/31/2023 | 440 | -211 | -59 | -3 | N/A |
12/31/2022 | 421 | -207 | -111 | -34 | N/A |
9/30/2022 | 419 | -51 | -152 | -40 | N/A |
6/30/2022 | 406 | -21 | -165 | -40 | N/A |
3/31/2022 | 399 | -6 | -148 | -29 | N/A |
12/31/2021 | 358 | -17 | -128 | -28 | N/A |
9/30/2021 | 294 | -42 | -82 | -15 | N/A |
6/30/2021 | 243 | -38 | -43 | -3 | N/A |
3/31/2021 | 180 | -27 | -15 | 8 | N/A |
12/31/2020 | 155 | -25 | 21 | 35 | N/A |
9/30/2020 | 140 | -41 | 18 | 32 | N/A |
6/30/2020 | 126 | -16 | -1 | 18 | N/A |
3/31/2020 | 109 | -42 | -8 | 11 | N/A |
12/31/2019 | 75 | -164 | -11 | 4 | N/A |
9/30/2019 | 43 | -191 | -7 | -1 | N/A |
6/30/2019 | 11 | -242 | 0 | 0 | N/A |
3/31/2019 | N/A | -209 | -1 | -1 | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: AYR.A is forecast to remain unprofitable over the next 3 years.
Kazançlar ve Piyasa: AYR.A is forecast to remain unprofitable over the next 3 years.
Yüksek Büyüme Kazançları: AYR.A is forecast to remain unprofitable over the next 3 years.
Gelir ve Pazar: AYR.A's revenue (7.6% per year) is forecast to grow faster than the Canadian market (6.9% per year).
Yüksek Büyüme Geliri: AYR.A's revenue (7.6% per year) is forecast to grow slower than 20% per year.
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: Insufficient data to determine if AYR.A's Return on Equity is forecast to be high in 3 years time